Adial Pharmaceuticals, Inc.ADILNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+6.2%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+6.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 86.95% |
| 2023 | 54.59% |
| 2022 | 54.13% |
| 2021 | -19.87% |
| 2020 | 0.05% |
| 2019 | 64.32% |
| 2018 | -1075.00% |
| 2017 | -136.36% |
| 2016 | 48.60% |
| 2015 | 0.00% |